PMC:7172841 / 1392-1678
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T15 | 80-83 | Body_part | denotes | HLA | http://purl.org/sig/ont/fma/fma84795 |
T16 | 95-104 | Body_part | denotes | monocytes | http://purl.org/sig/ont/fma/fma62864 |
T17 | 112-116 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T18 | 121-128 | Body_part | denotes | NK cell | http://purl.org/sig/ont/fma/fma63147 |
T19 | 124-128 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T20 | 21-40 | Disease | denotes | respiratory failure | http://purl.obolibrary.org/obo/MONDO_0021113 |
T21 | 170-178 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T22 | 225-233 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T23 | 225-229 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T13 | 60-61 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T14 | 95-104 | http://purl.obolibrary.org/obo/CL_0000576 | denotes | monocytes |
T15 | 108-111 | http://purl.obolibrary.org/obo/PR_000001004 | denotes | CD4 |
T16 | 112-116 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T17 | 121-128 | http://purl.obolibrary.org/obo/CL_0000623 | denotes | NK cell |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T12 | 84-86 | Chemical | denotes | DR | http://purl.obolibrary.org/obo/CHEBI_73445 |
T13 | 182-184 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T14 | 11-104 | Sentence | denotes | • Severe respiratory failure is associated with a major decrease of HLA-DR on CD14 monocytes |
T15 | 105-178 | Sentence | denotes | • CD4 cell and NK cell cytopenias are characteristics of severe COVID-19 |
T16 | 179-267 | Sentence | denotes | • IL-6 blocker Tocilizumab partially rescues SARS-CoV-2-associated immune dysregulation |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T9 | 21-40 | Phenotype | denotes | respiratory failure | http://purl.obolibrary.org/obo/HP_0002878 |
T10 | 247-267 | Phenotype | denotes | immune dysregulation | http://purl.obolibrary.org/obo/HP_0002958 |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T49 | 21-32 | UBERON:0001004 | denotes | respiratory |
T50 | 80-83 | PR:000029150 | denotes | HLA |
T51 | 90-94 | PR:000001889 | denotes | CD14 |
T52 | 95-104 | CL:0000576 | denotes | monocytes |
T53 | 170-178 | SP_7 | denotes | COVID-19 |
T54 | 182-186 | PR:000001393 | denotes | IL-6 |
T55 | 195-206 | DG_35 | denotes | Tocilizumab |
T56 | 225-235 | SP_7 | denotes | SARS-CoV-2 |
T57 | 254-267 | GO:0065007 | denotes | dysregulation |
T35889 | 21-32 | UBERON:0001004 | denotes | respiratory |
T52417 | 80-83 | PR:000029150 | denotes | HLA |
T73916 | 90-94 | PR:000001889 | denotes | CD14 |
T86003 | 95-104 | CL:0000576 | denotes | monocytes |
T91561 | 170-178 | SP_7 | denotes | COVID-19 |
T288 | 182-186 | PR:000001393 | denotes | IL-6 |
T45776 | 195-206 | DG_35 | denotes | Tocilizumab |
T71931 | 225-235 | SP_7 | denotes | SARS-CoV-2 |
T97850 | 254-267 | GO:0065007 | denotes | dysregulation |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
74 | 90-94 | Gene | denotes | CD14 | Gene:929 |
75 | 21-40 | Disease | denotes | respiratory failure | MESH:D012131 |
79 | 108-111 | Gene | denotes | CD4 | Gene:920 |
80 | 121-139 | Disease | denotes | NK cell cytopenias | MESH:D054066 |
81 | 170-178 | Disease | denotes | COVID-19 | MESH:C000657245 |
85 | 182-186 | Gene | denotes | IL-6 | Gene:3569 |
86 | 225-235 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
87 | 195-206 | Chemical | denotes | Tocilizumab | MESH:C502936 |